CX3CR1 expression is recognised as a mediator of disease severity in kidney disease, with immunotherapeutic inhibition of CX3CR1 shown effective against glomerulonephritis.30, 31, 32. This evidence concerns the gene CX3CR1 and glomerulonephritis.